Enhanced Antiaging Effect of Fermented Ginseng through Biotransformation of Protopanaxadiol (PPD)-Type Ginsenosides to PPD

Aging couples oxidative stress, inflammation, and leaky gut; ginsenosides are promising yet hobbled by poor conversion. We asked whether probiotic fermentation enriching PPD-type ginsenosides converts ginseng into a potent, low-dose antiaging agent. In D-galactose-aged mice, 20 mg/kg of probiotic-fermented ginseng (GFB) outperformed 600 mg/kg native ginseng: Rg3/Rg5/Rd and antioxidant capacity surged, cytokines fell, redox balance, barrier integrity, and youthful microbiota were restored. Plasma 20(S)-protopanaxadiol (PPD) increased 4–6-fold only in fermented-ginseng mice; PPD down-regulated barrier-destabilizing genes and docked stably into CC-chemokine receptor 6 (CCR6), suggesting a potential mechanism for blocking CCL20-driven chemotaxis. Thus, fermentation transforms ginseng into a food-grade, microbe-activated pro-drug that delivers systemic PPD, antagonizes CCR6, and simultaneously quells inflammation, seals the gut, and resets redox homeostasis for precision geroprotection.